Search

Financial results - EMMES BIOPHARMA ROMANIA S.R.L.

0.00
Financial Summary - Emmes Biopharma Romania S.r.l.
Unique identification code: 36750917
Registration number: J40/15170/2016
Nace: 7219
Sales - Ron
45.286
Net Profit - Ron
-2.804
Employees
1
Open Account
Company Emmes Biopharma Romania S.r.l. with Fiscal Code 36750917 recorded a turnover of 2024 of 45.286, with a net profit of -2.804 and having an average number of employees of 1. The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Emmes Biopharma Romania S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 0 0 0 0 2.219 3.539 8.231 37.122 45.286
Total Income - EUR - 0 0 0 0 2.460 3.858 8.292 38.324 45.437
Total Expenses - EUR - 1.544 3.984 3.047 3.724 3.864 5.284 12.615 43.568 48.135
Gross Profit/Loss - EUR - -1.544 -3.984 -3.047 -3.724 -1.404 -1.426 -4.323 -5.244 -2.698
Net Profit/Loss - EUR - -1.544 -3.984 -3.047 -3.724 -1.478 -1.538 -4.447 -5.627 -2.804
Employees - 0 0 0 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 22.7%, from 37.122 euro in the year 2023, to 45.286 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Emmes Biopharma Romania S.r.l.

Rating financiar

Financial Rating -
EMMES BIOPHARMA ROMANIA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Emmes Biopharma Romania S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Emmes Biopharma Romania S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Emmes Biopharma Romania S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Emmes Biopharma Romania S.r.l. - CUI 36750917

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 0 0 0 0 0 0 0 164 163
Current Assets - 225 221 750 661 2.038 1.087 7.676 5.384 51.087
Inventories - 0 0 0 0 0 0 0 0 0
Receivables - 180 177 174 216 735 724 729 3.787 49.499
Cash - 45 44 576 445 1.304 363 6.947 1.597 1.588
Shareholders Funds - -1.499 -5.458 -8.190 -11.910 -13.162 -14.408 -18.899 -24.469 -27.136
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 1.724 5.860 9.237 12.751 15.408 15.701 26.544 29.188 76.207
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 51.087 euro in 2024 which includes Inventories of 0 euro, Receivables of 49.499 euro and cash availability of 1.588 euro.
The company's Equity was valued at -27.136 euro, while total Liabilities amounted to 76.207 euro. Equity decreased by -2.804 euro, from -24.469 euro in 2023, to -27.136 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Emmes Biopharma Romania S.r.l.

Comments - Emmes Biopharma Romania S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.